WallStSmart
INSM

Insmed Inc

NASDAQ: INSM · HEALTHCARE · BIOTECHNOLOGY

$135.03
+0.07% today

Updated 2026-04-29

Market cap
$29.15B
P/E ratio
P/S ratio
48.06x
EPS (TTM)
$-6.42
Dividend yield
52W range
$64 – $213
Volume
2.3M

Insmed Inc (INSM) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-42.20M$-25.25M$-11.99M$-11.01M$-7.72M$-30.20M$-31.01M$-46.66M$-64.42M$-100.70M$-146.71M$-159.62M$-257.98M$-250.65M$-219.35M$-363.30M$-400.44M$-536.25M$-683.88M$-935.01M
Capital expenditures$5.02M$0.00$0.00$0.00$6.73M$979000.00$290000.00$826000.00$5.35M$3.45M$4.20M$3.00M$14.81M$42.27M$6.82M$7.29M$9.88M$13.29M$21.92M$32.56M
Depreciation
Stock-based comp$885000.00$521000.00$850000.00$2.54M$366000.00$1.60M$2.98M$8.67M$11.33M$15.59M$18.04M$18.07M$26.24M$26.97M$36.16M$46.02M$57.69M$74.78M$96.83M$152.71M
Free cash flow$-47.22M$-25.25M$-11.99M$-11.01M$-14.46M$-31.18M$-31.30M$-47.49M$-69.77M$-104.15M$-150.91M$-162.62M$-272.79M$-292.92M$-226.17M$-370.59M$-410.32M$-549.53M$-705.80M$-967.58M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$4.11M$75.93M$23.11M$45.33M$123.65M$-120.28M$218.57M$113.91M$-7.64M$45.33M$184.96M$358.25M